Shanghai Pulse Medical Technology, Inc., founded in 2015, located in Shanghai, China, is dedicated to develop innovative technology for precise diagnosis and optimal treatment of patients with pan-vascular disease.

Together with our R&D partners, eg., Shanghai Jiao Tong University, Fuwai Hospital CAMS (Chinese Academy of Medical Sciences), Zhongshan Hospital affiliated to Fudan University, Oxford University, Aarhus University Hospital, Pulse Medical has been pioneering invented the key algorithm of Quantitative Flow Ratio, the fast computation methodology of fractional flow reserve (FFR) from multiple imaging data.

The computed tomography based FFR (CT-μFR^®), angiography-based FFR solution (Quantitative Flow Ratio in first generation, μFR^® in 2nd generation) and intracoronary IVUS or OCT-based FFR (UFR, OFR) have been commercialized.

Our mission is to deliver the innovative and valuable solutions to improve patient outcomes.